Pereira Rebeca Cristina Costa, Lourenço André Luiz, Terra Luciana, Abreu Paula Alvarez, Laneuville Teixeira Valéria, Castro Helena Carla
Programa de Pós-Graduação em Ciências e Biotecnologia (PPBI), Instituto de Biologia, Universidade Federal Fluminense, Niterói 24210-130, RJ, Brazil.
Laboratório de Trombose e Câncer, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21944-970, RJ, Brazil.
Mar Drugs. 2017 Mar 20;15(3):79. doi: 10.3390/md15030079.
Thrombosis related diseases are among the main causes of death and incapacity in the world. Despite the existence of antithrombotic agents available for therapy, they still present adverse effects like hemorrhagic risks which justify the search for new options. Recently, pachydictyol A, isopachydictyol A, and dichotomanol, three diterpenes isolated from Brazilian marine brown alga were identified as potent antithrombotic molecules through inhibition of thrombin, a key enzyme of coagulation cascade and a platelet agonist. Due to the biotechnological potential of these marine metabolites, in this work we evaluated their binding mode to thrombin in silico and identified structural features related to the activity in order to characterize their molecular mechanism. According to our theoretical studies including structure-activity relationship and molecular docking analysis, the highest dipole moment, polar surface area, and lowest electronic density of dichotomanol are probably involved in its higher inhibition percentage towards thrombin catalytic activity compared to pachydictyol A and isopachydictyol A. Interestingly, the molecular docking studies also revealed a good shape complementarity of pachydictyol A and isopachydictyol A and interactions with important residues and regions (e.g., H57, S195, W215, G216, and loop-60), which probably justify their thrombin inhibitor effects demonstrated in vitro. Finally, this study explored the structural features and binding mode of these three diterpenes in thrombin which reinforced their potential to be further explored and may help in the design of new antithrombotic agents.
血栓形成相关疾病是全球主要的死亡和致残原因之一。尽管有抗血栓药物可用于治疗,但它们仍然存在诸如出血风险等不良反应,这使得寻找新的治疗选择成为必要。最近,从巴西海洋褐藻中分离出的三种二萜类化合物——厚叶藻醇A、异厚叶藻醇A和二歧藻醇,通过抑制凝血酶(凝血级联反应的关键酶和血小板激动剂)被鉴定为强效抗血栓分子。由于这些海洋代谢产物具有生物技术潜力,在本研究中,我们通过计算机模拟评估了它们与凝血酶的结合模式,并确定了与活性相关的结构特征,以表征其分子机制。根据我们包括构效关系和分子对接分析在内的理论研究,与厚叶藻醇A和异厚叶藻醇A相比,二歧藻醇的最高偶极矩、极性表面积和最低电子密度可能与其对凝血酶催化活性的更高抑制率有关。有趣的是,分子对接研究还揭示了厚叶藻醇A和异厚叶藻醇A具有良好的形状互补性,以及与重要残基和区域(如H57、S195、W215、G216和60环)的相互作用,这可能解释了它们在体外表现出的凝血酶抑制作用。最后,本研究探索了这三种二萜类化合物在凝血酶中的结构特征和结合模式,进一步证实了它们有待深入研究的潜力,并可能有助于新型抗血栓药物的设计。